Ritedose Pharmaceuticals is donating 1 million doses of albuterol sulfate and levalbuterol inhalation solutions to Dispensary of Hope, supporting low-income and chronically ill patients nationwide.

RT’s Three Key Takeaways:

Donation: Ritedose Pharmaceuticals is donating 1 million doses of respiratory medications, specifically albuterol sulfate and levalbuterol inhalation solutions, to Dispensary of Hope to aid low-income and chronically ill patients across the United States.
Expanded Support: This donation represents an increase from last year’s donation, which included over 124,560 doses of respiratory medications.
Dispensary of Hope: Dispensary of Hope has distributed more than 750 million doses of medications to patients since its inception in 2003.

Ritedose Pharmaceuticals, a division of The Ritedose Corp, announced it will donate 1 million doses of respiratory medications to Dispensary of Hope, a national charitable medication distributor, to support low-income and chronically ill patients across the country.

In 2023, Ritedose Pharmaceuticals donated more than 77,760 doses of ipratropium bromide and 46,800 doses of levalbuterol inhalation solution.

Based on the positive impact these donations had on patients in need, Ritedose Pharmaceuticals increased its donation this year and will be manufacturing the following medications for Dispensary of Hope:

Albuterol sulfate inhalation solution
Levalbuterol inhalation solution

“Dispensary of Hope is beyond pleased that our partner, Ritedose, is pledging 1 million doses of respiratory medications to support the medical needs of underserved patients that receive access to our medications through the network of nonprofit clinics and pharmacies. These medicines will benefit thousands of patients nationwide,” says Dispensary of Hope chief supply chain officer Scott Cornwell in a release.

Dispensary of Hope

Founded in 2003, Dispensary of Hope is a nonprofit organization that partners with pharmaceutical companies and manufacturers such as Ritedose to distribute essential maintenance medications to pharmacies and safety-net clinics across the country for low-income and chronically ill patients.

In 2023, Dispensary of Hope provided more than 1.2 million prescriptions to patients across its network. Since its inception, Dispensary of Hope has provided more than 750 million doses to patients.

“Dispensary of Hope’s mission to provide needed medications for low-income and chronically ill patients is a mission Ritedose is proud to support and one we wholeheartedly embrace,” says CEO of Ritedose Jody Chastain in a release. “The products we will directly manufacture for Dispensary of Hope are those needed most to treat multiple respiratory conditions. We have an obligation to take care of patients and partnering with Dispensary of Hope is one way we can fulfill that mission.”